These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Outcomes of a minimally invasive surgical approach to manage persistent high-grade vesicoureteric reflux post successful augmentation cystoplasty of patients with non-compliant bladder. Alsowayan O, Barham A, Alqarni N, Alnazari M, Alsakharni M, Ewida T, Trbay M, Elderwy AA, Alhazmi H, Neel KF. J Pediatr Urol; 2015 Apr; 11(2):60.e1-4. PubMed ID: 25294281 [Abstract] [Full Text] [Related]
4. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Krebs J, Bartel P, Pannek J. Neurourol Urodyn; 2016 Feb; 35(2):260-6. PubMed ID: 25524480 [Abstract] [Full Text] [Related]
5. [Prognostics factors of renal failure in multiple sclerosis]. Viart L, Elalouf V, Petit J, Al Khedr A, Kristkowiak P, Saint F. Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100 [Abstract] [Full Text] [Related]
6. Evaluation of augmentation cystoplasty in childhood with reference to vesico-ureteric reflux and urinary infection. Krishna A, Gough DC. Br J Urol; 1994 Oct; 74(4):465-8. PubMed ID: 7820425 [Abstract] [Full Text] [Related]
7. Evaluation of augmentation cystoplasty for severe neuropathic bladder using the hostility score. Khoury JM, Webster GD. Dev Med Child Neurol; 1992 May; 34(5):441-7. PubMed ID: 1592197 [Abstract] [Full Text] [Related]
14. Urodynamic comparison of ileum vs. sigmoid in augmentation cystoplasty for neurogenic bladder dysfunction. Radomski SB, Herschorn S, Stone AR. Neurourol Urodyn; 1995 Jan; 14(3):231-7. PubMed ID: 7647805 [Abstract] [Full Text] [Related]
15. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Schulte-Baukloh H, Schobert J, Stolze T, Stürzebecher B, Weiss C, Knispel HH. Neurourol Urodyn; 2006 Jan; 25(2):110-5. PubMed ID: 16470519 [Abstract] [Full Text] [Related]
16. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study]. Martín C, Salinas J, Fernández-Durán A, Fernández-Gómez J, Jiménez N, Gangoiti L. Rev Neurol; 2006 Jan; 30(7):643-8. PubMed ID: 10859743 [Abstract] [Full Text] [Related]
17. Small bowel augmentation in children with neurogenic bladder: an initial report of urodynamic findings. Decter RM, Bauer SB, Mandell J, Colodny AH, Retik AB. J Urol; 1987 Oct; 138(4 Pt 2):1014-6. PubMed ID: 3656556 [Abstract] [Full Text] [Related]
18. Augmentation cystoplasty: Urodynamic and metabolic outcomes at 10-year follow-up. Cheng KC, Kan CF, Chu PS, Man CW, Wong BT, Ho LY, Au WH. Int J Urol; 2015 Dec; 22(12):1149-54. PubMed ID: 26391472 [Abstract] [Full Text] [Related]